Europe's Vaccine Rollout Relies Heavily On Pfizer/BioNTech Europe’s Vaccine Rollout Relies Heavily On Pfizer/BioNTech As Europe’s vaccine rollout is picking up pace, Statista’s Felix Richter reports that the European Commission is doubling down on its use of mRNA vaccines, with the Pfizer/BioNTech shot central to its inoculation efforts. According to a statement, the European Commission is …
Saving...